BBPvsCANCETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) and Tema Oncology ETF (CANC) belong to the same industry segment: Tomorrow's Treatments. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is less expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.99% for CANC. BBP is up 9.25% year-to-date (YTD) with +$30M in YTD flows. CANC performs worse with 8.22% YTD performance, and +$52M in YTD flows. Run a side-by-side ETF comparison of BBP and CANC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs CANC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP CANC | -1.38%-0.48% | +7.00%+3.95% | +9.25%+8.22% | +43.65%+45.49% | +60.05%n/a | +58.90%n/a |
| Flows | BBP CANC | +$4M+$5M | +$26M+$11M | +$30M+$52M | +$42M+$69M | +$45M- | +$38M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP CANC | +28.75%+24.37% | +24.06%+22.62% | +24.00%n/a | +26.36%n/a |
| Max drawdown | BBP CANC | -7.49%-9.20% | -9.59%-9.20% | -25.54%n/a | -37.87%n/a |
| Max drawdown duration | BBP CANC | 37d54d | 48d54d | 292dn/a | 760dn/a |
Trading data
BBP | CANC | |
Last sale 6/12/2026 at 1:30 PM | $87.17 | $37.48 |
| Previous close 06/11/2026 | $86.80 | $37.26 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
CANC
is actively managed and doesn’t replicate an indexBBP | CANC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
BBP | CANC | |
|---|---|---|
| Last price | $87.17 | $37.48 |
| 1D performance | +0.42% | +0.60% |
| AuM | $78.43 M | $178.42 M |
| E/R | 0.79% | 0.99% |
Characteristics
BBP | CANC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Tema |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 55 | 42 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | August 15, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
84.13%
Other
15.87%
CANC
USA
87.11%
Other
12.89%
Sectors
BBP
Health Care
85.97%
Other
14.03%
CANC
Health Care
76.64%
Other
23.36%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
45.32%
CANC
Total weight of top 15 holdings out of 15
54.47%
Top 15 holdings
Data as of April 30, 2026
BBP
ARROWHEAD PHARMACEUTICALS INC
3.17%
GB00BRXB0C07
3.17%
BIOGEN INC
3.14%
HALOZYME THERAPEUTICS
3.13%
AURINIA PHARMACEUTICALS INC
3.12%
SYNDAX PHARMACEUTICALS INC
3.12%
BIOMARIN PHARMACEUTICAL
3.05%
INCYTE
3.03%
REGENERON PHARMACEUTICALS
3.03%
BRIDGEBIO PHARMA
3.00%
SAREPTA THERAPEUTICS INC DE
2.95%
ARDELYX
2.92%
VERTEX PHARMACEUTICALS
2.85%
US07725L1026
2.83%
THERAVANCE BIOPHARMA
2.80%
CANC
REVOLUTION MEDICINES INC
6.51%
IMMUNOME
4.24%
US7711951043
4.15%
COGENT BIOSCIENCES
4.07%
NOVARTIS
4.00%
LILLY
3.81%
ASTRAZENECA
3.62%
BRISTOL-MYERS SQUIBB
3.36%
MERCK & CO INC
3.34%
CELCUITY INC
3.31%
NUVALENT
3.20%
BRIDGEBIO PHARMA
2.84%
US3723032062
2.82%
LEGEND BIOTECH
2.63%
US98887Q1040
2.57%
Frequently asked questions about BBP and CANC
How have the BBP and CANC ETFs performed in 2026?
As of June 12, 2026, BBP is up 9.25% year-to-date (YTD), while CANC has returned 8.22%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or CANC?
Year-to-date, the BBP ETF saw +$30M in flows, compared to +$52M for CANC.
Which ETF is more volatile: BBP or CANC?
Over the past year, BBP had a volatility of 24.06%, while CANC experienced 22.62%.
Which ETF is bigger: BBP or CANC?
As of June 12, 2026, BBP holds $78.43 M in assets under management (AUM), while CANC manages $178.42 M.
What sectors do the BBP and CANC ETFs invest in?
BBP leans toward sectors like Health Care. Meanwhile, CANC focuses on Health Care.
What are the top holdings of the BBP ETF and CANC ETF?
BBP top holdings include ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC. CANC holds in its top three: REVOLUTION MEDICINES INC, IMMUNOME and US7711951043.
Which ETF is more diversified: BBP or CANC?
BBP holds 59 securities with 45.32% of its assets in the top 15. CANC has 53 securities and a top 15 weight of 54.47%.
Advertisement
Advertisement
